Rémy Cointreau (RMC) H1 24/25 TU earnings summary
Event summary combining transcript, slides, and related documents.
H1 24/25 TU earnings summary
18 Jan, 2026Executive summary
Q2 2024-25 organic sales declined 16.1%, with H1 sales at €533.7M, down 15.9% year-on-year, driven by US destocking, weak depletions, high comps in China, and soft global consumption.
Americas sales fell 22.8% in H1, APAC down 8%, and EMEA down 18.8%, all impacted by challenging market conditions and consumer trends.
Q2 sales performance reflected an 8.0% volume effect and an 8.1% price-mix effect.
Value depletions improved sequentially but remained negative; group value depletions down low double digits year-on-year.
Financial highlights
H1 organic sales decrease of 15.9%, with a strong negative volume effect (-13.5%) and a smaller negative price/mix (-2.4%).
Cognac division H1 organic sales declined 17.5% (volume -14.2%, price/mix -3.3%), now 64% of group sales; Liqueurs & Spirits down 12% (volume -12.6%, price/mix +0.6%), now 34% of group sales.
Partner Brands H1 organic sales down 25.0%.
Currency translation had a minor negative impact of €1.6M, mainly from the Chinese yuan and Japanese yen.
Outlook and guidance
Full-year 2024-25 guidance expects a double-digit organic sales decline and operating profit margin deterioration, partially offset by a €50M+ cost-cutting plan.
No sales recovery in Americas expected before Q4 2024-25; APAC to see further sequential deterioration in H2; EMEA to remain sluggish.
2024-25 is a transition year; high single-digit annual organic sales growth expected to resume from 2025-26, with gradual margin improvement through 2029-30.
Exchange rates expected to impact sales by -€5M to -€10M and COP by +€3M to +€7M.
Latest events from Rémy Cointreau
- Q3 organic sales up 2.8% as U.S. and EMEA gains offset APAC and China weakness.RMC
Q3 2026 TU3 Feb 2026 - Q1 sales dropped 15.6% organically, with gradual recovery and cost controls underway.RMC
Q1 24/25 TU3 Feb 2026 - Sales and profit dropped, but cost savings and recovery with high single-digit growth are targeted.RMC
H2 23/241 Feb 2026 - Sales and profit dropped, but margins held up due to aggressive cost controls.RMC
H1 24/2512 Jan 2026 - Q3 sales fell 21.5% organically; full-year decline near 18% with margin guidance held.RMC
Q3 24/25 TU9 Jan 2026 - Sales fell 18% organically; margin guidance held, cost savings and tariff risks remain.RMC
Q4 24/25 TU29 Nov 2025 - Sales and profit declined, but transformation and investment in recovery continue.RMC
H1 25/2627 Nov 2025 - Sales and profit fell sharply, but cost savings and a US rebound support cautious optimism.RMC
H2 24/2521 Nov 2025 - H1 sales dropped 4.2% organically, prompting a guidance cut amid China and currency headwinds.RMC
Q2 25/26 TU31 Oct 2025